LFCR Lifecore Biomedical Inc

Price (delayed)

$4.4

Market cap

$166.55M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.16

Enterprise value

$303.41M

?
Relative Growth: Rel. Growth: 25
Relative Strength: Rel. Strength: 15
Relative Valuation: Rel. Valuation: 25
Relative Profitability: Rel. Profitability: 20

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract ...

Highlights
The company's quick ratio rose by 48% YoY and by 12% QoQ
LFCR's EPS is up by 9% YoY
Lifecore Biomedical's debt has increased by 21% YoY and by 4.3% from the previous quarter
LFCR's equity is down by 20% since the previous quarter

Key stats

What are the main financial stats of LFCR

LFCR stock price

How has the Lifecore Biomedical stock price performed over time
Intraday
-2.11%
1 week
5.77%
1 month
-3.08%
1 year
-44.3%
YTD
-46.21%
QTD
-16.19%

Financial performance

How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$132.88M
Gross profit
$40.23M
Operating income
-$2.84M
Net income
-$39.1M
Gross margin
30.3%
Net margin
-29.4%
The company's operating income has surged by 84% YoY
LFCR's operating margin has soared by 84% YoY
The company's gross margin fell by 3.2% YoY
LFCR's revenue is up by 3.1% YoY

Price vs fundamentals

How does LFCR's price correlate with its fundamentals

Growth

What is Lifecore Biomedical's growth rate over time

Valuation

What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
N/A
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
115.89
EV/Sales
2.28
LFCR's EPS is up by 9% YoY
LFCR's equity is down by 20% since the previous quarter
The price to sales (P/S) is 40% lower than the 5-year quarterly average of 2.1
LFCR's revenue is up by 3.1% YoY

Efficiency

How efficient is Lifecore Biomedical business performance
LFCR's ROS has soared by 55% YoY
Lifecore Biomedical's return on invested capital has surged by 54% YoY
The ROA has contracted by 3.3% YoY

Dividends

What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFCR.

Financial health

How did Lifecore Biomedical financials performed over time
LFCR's total assets is 8% more than its total liabilities
The company's quick ratio rose by 48% YoY and by 12% QoQ
The company's current ratio rose by 36% YoY and by 2.1% QoQ
The debt to equity has shrunk by 105% YoY but it is up by 13% QoQ
Lifecore Biomedical's debt has increased by 21% YoY and by 4.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.